Screener
Wave Life Sciences WVE Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $2,272 | $8,699 | $40,518 | $17,874 |
| Operating expenses: | ||||
| Research and development | 51,293 | 43,469 | 98,733 | 84,091 |
| General and administrative | 24,781 | 17,989 | 46,884 | 36,346 |
| Total operating expenses | 76,074 | 61,458 | 145,617 | 120,437 |
| Loss from operations | (73,802) | (52,759) | (105,099) | (102,563) |
| Other income, net: | ||||
| Interest income | 4,722 | 2,372 | 10,013 | 5,247 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's total revenue?
- Wave Life Sciences (WVE) reported total revenue of $2.27M in Q2 2026.
- How has Wave Life Sciences's total revenue changed year-over-year?
- Wave Life Sciences's total revenue decreased by 73.9% year-over-year, from $8.7M to $2.27M.
- What is the long-term trend for Wave Life Sciences's total revenue?
- Over 2 years (2021 to 2023), Wave Life Sciences's total revenue has grown at a 66.3% compound annual growth rate (CAGR), from $40.96M to $113.31M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Wave Life Sciences's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude